Loading...

PE/Cyanine7 anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_PECyanine7_CD11c_Antibody_1_111924
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE/Cyanine7 N418 (left) or PE/Cyanine7 Armenian hamster IgG isotype control (right)
  • N418_PECyanine7_CD11c_Antibody_1_111924
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE/Cyanine7 N418 (left) or PE/Cyanine7 Armenian hamster IgG isotype control (right)
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
117317 25 µg 76€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117318 100 µg 185€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  2. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  3. Jiang Z, et al. 2021. J Clin Invest. 131: . PubMed
  4. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  5. Friess MC, et al. 2022. Cell Rep. 38:110334. PubMed
  6. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  7. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  8. Kimura S, et al. 2020. Nat Commun. 0.620833333. PubMed
  9. Al–Rashed F, et al. 2020. Sci Rep. 10:16802. PubMed
  10. Pohlmeier L, et al. 2021. Allergy. 76:2030. PubMed
  11. Russler-Germain EV, et al. 2021. Immunity. 54:2547. PubMed
  12. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  13. Osokine I, et al. 2022. Cell Rep. 38:110329. PubMed
  14. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  15. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  16. Wang S, et al. 2022. Sci Adv. 8:eabn3883. PubMed
  17. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  18. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  19. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  20. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  21. Hill AA, et al. 2023. JCI Insight. 8: . PubMed
  22. Tatsumi N, et al. 2022. STAR Protoc. 3:101845. PubMed
  23. García-García A, et al. 2023. Bioact Mater. 24:174. PubMed
  24. Cousin N, et al. 2022. Cells. 12: . PubMed
  25. Sieow JL, et al. 2023. Int J Mol Sci. 24: . PubMed
  26. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  27. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  28. Wei J, et al. 2022. Cancer Prev Res (Phila). 15:285. PubMed
  29. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  30. Morris CR, et al. 2022. Mucosal Immunol. 15:977. PubMed
  31. Kedmi R, et al. 2022. Nature. 610:737. PubMed
  32. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  33. Lutz MB, et al. 2022. Eur J Immunol. . PubMed
  34. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  35. Barsheshet Y, et al. 2022. Int J Mol Sci. 23:. PubMed
  36. Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed
  37. Rocca Y, et al. 2023. Methods Mol Biol. 2618:187. PubMed
  38. Xu H, et al. 2023. Elife. 12:. PubMed
  39. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  40. Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed
  41. Shen Z, et al. 2023. iScience. 26:106572. PubMed
  42. He Y, et al. 2023. Biomolecules. 13:. PubMed
  43. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
  44. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  45. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  46. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  47. Jong RM, et al. 2022. J Immunol. 208:407. PubMed
  48. Ercoli G, et al. 2021. Front Immunol. 11:611661. PubMed
  49. Wiesner DL, et al. 2020. Cell Host Microbe. 614:27. PubMed
  50. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  51. Kolawole A, et al. 2015. J Virol. 90: 1499-1506. PubMed
  52. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  53. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  54. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  55. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  56. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  57. Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed
  58. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  59. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  60. Ndoja A, et al. 2020. Cell. 182(5):1156-1169.e12. PubMed
  61. Dong L, et al. 2021. Cancer Cell. . PubMed
  62. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  63. Shen Y, et al. 2021. Comput Struct Biotechnol J. 19:5360. PubMed
  64. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  65. Boldison J, et al. 2020. Cell Mol Immunol. 17:843. PubMed
  66. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  67. Clarke F,et al. 2017. PLoS One. 10.1371/journal.pone.0186625. PubMed
  68. Thwe PM et al. 2017. Cell metabolism. 26(3):558-567 . PubMed
  69. Kurelac I, et al. 2019. Nat Commun. 10:903. PubMed
  70. Quatrini L, et al. 2018. Nat Immunol. 19:954. PubMed
  71. Suzuki T, et al. 2014. J Dermatol Sci. 74:116. PubMed
  72. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  73. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  74. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  75. Yu X, et al. 2021. Nature. 594:560. PubMed
  76. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  77. Hearnden R, et al. 2021. STAR Protocols. 2(2):100422. PubMed
  78. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  79. Ku M, et al. 2016. Mol Cancer Ther. 15: 1975 - 1987. PubMed
  80. Wong E, et al. 2019. Cell Rep. 29:3047. PubMed
  81. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  82. Morgado P, et al. 2014. Infect Immun . 82:4047. PubMed
  83. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  84. Bazett M, Haston M 2016. Sci Rep. 6:19189. PubMed
  85. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  86. Si Y, et al. 2020. Sci Adv. 6:eaba0995. PubMed
  87. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  88. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  89. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  90. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  91. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  92. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  93. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  94. Sato Y, et al. 2021. J Clin Invest. Online ahead of print. PubMed
  95. Bagayoko S, et al. 2021. PLoS Pathog. 17:e1009927. PubMed
  96. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  97. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  98. van Dierendonck XAMH, et al. 2020. Cell Reports. 30(6):1811-1822. PubMed
  99. Nguyen CM, et al. 2019. Diabetes. 68:1499. PubMed
  100. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  101. Lyons J, et al. 2018. Sci Signal. 11. PubMed
  102. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  103. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  104. Zhang C, et al. 2021. Clin Transl Immunology. 10:e1310. PubMed
  105. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  106. Škrnjug I, et al. 2014. PLoS One. 9:110150. PubMed
  107. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  108. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  109. Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed
  110. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  111. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
  112. An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed
  113. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  114. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  115. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  116. Zeng J, et al. 2019. Cell Rep. 27:549. PubMed
  117. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  118. Wu X, et al. 2021. Elife. 10:. PubMed
  119. Crosse EI, et al. 2020. Cell Stem Cell. 27:822. PubMed
  120. Sellau J, et al. 2016. Sci Rep. 6:28058. PubMed
  121. Rosen D, et al. 2016. J Infect Dis. 213: 649 - 658. PubMed
  122. Kelsey E Sivick et al. 2018. Cell reports. 25(11):3074-3085 . PubMed
  123. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  124. Novkovic M, et al. 2016. PLoS Biol. 14: 1002515. PubMed
  125. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  126. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  127. Connick K, et al. 2020. J Parasit Dis. 186:44. PubMed
  128. Johnson LA, et al. 2021. Life Sci Alliance. :4. PubMed
  129. Deng M, et al. 2020. Nat Commun. 11:2193. PubMed
  130. Si Y, et al. 2018. J Control Release. 282:120. PubMed
  131. Baudoux T, et al. 2018. Sci Rep. 4.0375. PubMed
  132. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
  133. Pan Y, et al. 2022. J Clin Invest. 132:. PubMed
  134. Kim S, et al. 2022. Redox Biol. 54:102347. PubMed
  135. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  136. Ercoli G, et al. 2022. Clin Transl Immunology. 11:e1366. PubMed
  137. Lewis EL, et al. 2021. Front Immunol. 12:741518. PubMed
  138. Panea C, et al. 2021. Commun Biol. 4:913. PubMed
  139. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  140. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  141. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  142. Vettorazzi S, et al. 2015. Nat Commun. 6: 7796. PubMed
  143. Christ A, et al. 2018. Cell. 172:162. PubMed
  144. Calcinotto A, et al. 2018. Nat Commun. 9:4832. PubMed
  145. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  146. Krollmann C, et al. 2022. STAR Protoc. 3:101309. PubMed
  147. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  148. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  149. Schaefer K, et al. 2014. PLoS One. 9:114824. PubMed
  150. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  151. Kim SH, et al. 2021. Cell Reports. 35(2):108995. PubMed
  152. Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed
  153. Hiebert P et al. 2018. Developmental cell. 46(2):145-161 . PubMed
  154. Tran NT, et al. 2020. STAR Protocols. 1(1):100028. PubMed
  155. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  156. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  157. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  158. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  159. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  160. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  161. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  162. Reimer E, et al. 2020. J Cell Sci. 134:00:00. PubMed
  163. Cuenca M, et al. 2016. J Immunol. 196: 726 - 737. PubMed
  164. Hayashi K, et al. 2015. Int Immunol. 27: 435-445. PubMed
  165. Ermert D, et al. 2016. PLoS Pathog. 11: 1005043. PubMed
  166. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  167. Yang C, et al. 2019. Nanomedicine (Lond). 14:2423. PubMed
  168. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  169. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  170. Colliou N, et al. 2015. Toxins. 7: 3805 - 3817. PubMed
  171. Shepardson K, et al. 2016. MBio. 7: e00506-16. PubMed
  172. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  173. Lan H, et al. 2020. Int Immunol. 559:32. PubMed
  174. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  175. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  176. Yang X, et al. 2022. Front Immunol. 13:856230. PubMed
  177. Clement CC, et al. 2021. Immunity. 54:721. PubMed
  178. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  179. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  180. Kim M, et al. 2018. Immunity. 49:151. PubMed
  181. Lu Y, et al. 2020. Immunity. 52:782. PubMed
  182. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  183. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  184. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  185. Zwick M, et al. 2019. Front Immunol. 10:222. PubMed
  186. Chan WY, et al. 2019. Infect Immun. 87:. PubMed
  187. Ghorbani S, et al. 2022. Nat Commun. 13:2445. PubMed
  188. Velázquez F, et al. 2016. J Immunol. 196: 1305 - 1316. PubMed
  189. Ghosh D, et al. 2016. J Immunol. 197: 1788 - 1800. PubMed
  190. Yasuda T, et al. 2016. PLoS One. 11:e0167952. PubMed
  191. Kumari P, et al. 2021. Cell Reports. 35(3):109012. PubMed
  192. Liu P, et al. 2020. Mol Cell. 748:77. PubMed
  193. Li E, et al. 2021. Front Immunol. 12:667177. PubMed
  194. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  195. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  196. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  197. Lai SM et al. 2018. Cell reports. 25(11):3099-3109 . PubMed
  198. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  199. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  200. Hennion-Tscheltzoff O, et al. 2013. Blood. 121:4684. PubMed
  201. Škrnjug I, et al. 2014. PLoS One. 9:95728. PubMed
  202. Walker MT, et al. 2021. Front. Allergy. 2:. PubMed
  203. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  204. Harb H, et al. 2020. Nat Immunol. 1359:21. PubMed
  205. Niven J, et al. 2019. Cell Rep. 28:21. PubMed
  206. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  207. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  208. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  209. Chung S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. L921:318. PubMed
  210. Stefan KL, et al. 2020. Cell. 1312:183. PubMed
  211. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  212. Okreglicka K, et al. 2021. J Exp Med. 218:. PubMed
  213. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  214. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  215. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  216. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  217. Lee HN, et al. 2022. JCI Insight. 7:. PubMed
  218. Verma M, et al. 2021. J Exp Med. 218:. PubMed
  219. Kim J, et al. 2020. Adv Funct Mater. 30:. PubMed
  220. Lee GR, et al. 2021. JCI Insight. 6:. PubMed
  221. Van Nuffel E, et al. 2020. EMBO Rep. 21:e49237. PubMed
  222. Liu SS, et al. 2021. Immunity. :. PubMed
  223. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  224. Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed
  225. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  226. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  227. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  228. Jin J, et al. 2020. Cell Reports. 30(12):4124-4136. PubMed
  229. Schuh E, et al. 2017. J Immunol. 198:3081. PubMed
  230. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  231. Fite BZ, et al. 2021. Sci Rep. 11:927. PubMed
  232. Stotesbury C, et al. 2020. Aging Cell. 19:e13170. PubMed
  233. Teng F, et al. 2021. Cell Rep. 37:110051. PubMed
  234. Ceglia V, et al. 2021. J Immunol. 207:2060. PubMed
  235. Bahmani B, et al. 2021. Nat Commun. 12:1999. PubMed
  236. Stack G, et al. 2015. PLoS Pathog. 11:1004641. PubMed
  237. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  238. Goc J, et al. 2021. Cell. 184:5015. PubMed
  239. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  240. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  241. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  242. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  243. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  244. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  245. Saleh R, et al. 2018. J Immunol. 201:2042. PubMed
  246. Doo DW, et al. 2020. Ther Adv Med Oncol. 12:1758835920913798. PubMed
  247. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  248. Dietschmann A, et al. 2020. Eur J Immunol. 50:1044. PubMed
  249. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  250. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  251. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  252. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  253. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  254. Fontana C, et al. 2016. J Biol Chem. 291: 7727-7741. PubMed
  255. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  256. Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
  257. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  258. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  259. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
RRID
AB_493568 (BioLegend Cat. No. 117317)
AB_493568 (BioLegend Cat. No. 117318)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Spark PLUS UV395™ anti-mouse CD11c N418 FC
Spark Blue™ 574 anti-mouse CD11c (Flexi-Fluor™) N418 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account